Legal Insights on Diversion: DEA Regulatory Updates, Government Enforcement Trends, and Lessons for Diversion Prevention Teams



Type of event:


The panel will provide an update on recent regulatory changes, new rules, and new guidance issued by the U.S. Drug Enforcement Administration (DEA) and discuss how those changes affect healthcare facilities. The panel will address government enforcement trends and priorities that affect healthcare facilities by discussing recent government enforcement actions and settlements and by sharing insights from our experience as outside counsel representing healthcare facilities in diversion events and enforcement matters. The panel will discuss how facility anti-diversion teams can use this information to improve their internal processes and in interactions with senior leadership and legal departments. The panel will close by providing additional best practices for responding to diversion events and DEA inspections.

Presented by Speakers

Photo of IHFDA Webinar Speaker Brian Irving

Brian Irving

Bass Berry & Sims

Brian Irving is the Co-Chair of Bass, Berry & Sims’ Controlled Substances Enforcement & Diversion Practice. Brian represents clients in government investigations and enforcement matters, focusing on controlled substances enforcement and diversion and healthcare fraud. Brian’s clients span a variety of industries, including healthcare, pharmacy, and government contracting. Brian has successfully represented clients in federal and state courts at both the trial and appellate levels, in administrative proceedings before federal agencies, and in arbitrations and other forms of alternative dispute resolution. Brian is the editor of the firm’s Inside the False Claims Act blog.

Hannah Choate

Bass Berry & Sims

Hannah Choate advises clients related to government and internal investigations, with a particular focus on fraud and abuse matters in the healthcare industry.  An active member of the firm’s Controlled Substances Enforcement and Diversion Practice, Hannah works with clients to respond to allegations of healthcare fraud and abuse from various regulators, including the Drug Enforcement Administration (DEA),the Department of Justice (DOJ), and various United States Attorneys’ Offices. Hannah draws on her experience as a former Assistant United States Attorney at the U.S. Attorney’s Office for the Western District of Kentucky, where she focused on Affirmative Civil Enforcement matters.

Garrah Carter-Mason

Bass Berry & Sims

Garrah Carter-Mason is an associate in the Litigation & Dispute Resolution Practice Group where she represents clients in government investigations, complex business litigation, and products liability claims. She is an active member of the firm’s Controlled Substances Enforcement and Diversion Practice. Garrah completed a clerkship with the Honorable Eli J. Richardson of the U.S. District Court for the Middle District of Tennessee.